In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.

This article unpacks the latest scientific findings and their implications for the future of cancer treatment.

Millions of Americans take antidepressants. And like all medication, they come with side effects. Researchers studied 30 ...

The ARASAFE study showed significant reductions in grade 3-5 adverse events and grade 3-4 neutropenia or death with a 50 ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...